rs886044450

Variant summary

Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong

The NM_000533.5(PLP1):​c.453G>A​(p.Lys151Lys) variant causes a splice region, synonymous change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: not found (cov: 22)

Consequence

PLP1
NM_000533.5 splice_region, synonymous

Scores

1
1
Splicing: ADA: 1.000
2

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:3

Conservation

PhyloP100: 6.58
Variant links:
Genes affected
PLP1 (HGNC:9086): (proteolipid protein 1) This gene encodes a transmembrane proteolipid protein that is the predominant component of myelin. The encoded protein may play a role in the compaction, stabilization, and maintenance of myelin sheaths, as well as in oligodendrocyte development and axonal survival. Mutations in this gene cause Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Alternatively splicing results in multiple transcript variants, including the DM20 splice variant. [provided by RefSeq, Feb 2015]
RAB9B (HGNC:14090): (RAB9B, member RAS oncogene family) This gene encodes a member of a subfamily of RAS small guanosine triphosphate (GTP)-binding proteins that regulate membrane trafficking. The encoded protein may be involved in endosome-to-Golgi transport. [provided by RefSeq, Jan 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 14 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
Splicing scoreres supports a deletorius effect: Scorers claiming Pathogenic: dbscSNV1_ADA, dbscSNV1_RF. No scorers claiming Uncertain. Scorers claiming Benign: max_spliceai.
PP5
Variant X-103786726-G-A is Pathogenic according to our data. Variant chrX-103786726-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 290425.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PLP1NM_000533.5 linkc.453G>A p.Lys151Lys splice_region_variant, synonymous_variant Exon 3 of 7 ENST00000621218.5 NP_000524.3 P60201-1A8K9L3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PLP1ENST00000621218.5 linkc.453G>A p.Lys151Lys splice_region_variant, synonymous_variant Exon 3 of 7 1 NM_000533.5 ENSP00000484450.1 P60201-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
22

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 2 Pathogenic:1
Apr 13, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

Nucleotide substitutions within the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Experimental studies have shown that this variant results in an aberrant transcript encoding a PLP1 with an in-frame 14-amino acid deletion within the PLP1-specific domain (PMID: 16287154). For these reasons, this variant has been classified as Pathogenic. Two different variants affecting this nucleotide (c.453G>T, c.453G>C) have been determined to be pathogenic (PMID: 7531827, 12601703, 16287154, 28366443). This suggests that this nucleotide is important for normal RNA splicing, and that other variants at this position may also be pathogenic. This variant has been reported in individuals affected with Pelizaeus-Merzbacher disease (PMD) (PMID: 12601703, 16287154). This variant is also known as G450A in the literature. ClinVar contains an entry for this variant (Variation ID: 290425). This variant is not present in population databases (ExAC no frequency). This sequence change affects codon 151 of the PLP1 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PLP1 protein. This variant also falls at the last nucleotide of exon 3 of the PLP1 coding sequence, which is part of the consensus splice site for this exon. -

not provided Pathogenic:1
Sep 06, 2016
Eurofins Ntd Llc (ga)
Significance: Pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Pelizaeus-Merzbacher disease Pathogenic:1
Dec 10, 2021
Molecular Diagnostics Lab, Nemours Children's Health, Delaware
Significance: Likely pathogenic
Review Status: criteria provided, single submitter
Collection Method: clinical testing

This variant (c.453G>A, p.Lys151=) is the last nucleotide af exon 3 and predicts a synonymous change. It has not been observed in population databases (gnomAD). It has been described in the literature, and functional studies indicate a deleterious effect on protein expression (PMID 16287154, PMID 30195779). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.34
CADD
Benign
22
DANN
Uncertain
0.99

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
1.0
dbscSNV1_RF
Pathogenic
1.0
SpliceAI score (max)
0.18
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs886044450; hg19: chrX-103041655; API